Literature DB >> 25870092

Sequencing and combining systemic therapies for pancreatic neuroendocrine tumors.

Matthew H Kulke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870092     DOI: 10.1200/JCO.2014.59.0927

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Sequence of therapy and survival in patients with advanced pancreatic neuroendocrine tumours.

Authors:  E S Tsang; J M Loree; C Speers; H F Kennecke
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

Review 2.  Pancreatic neuroendocrine tumors.

Authors:  Jian Sun
Journal:  Intractable Rare Dis Res       Date:  2017-02

3.  AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.

Authors:  Tracey L Smith; Ziqiang Yuan; Marina Cardó-Vila; Carmen Sanchez Claros; Asha Adem; Min-Hui Cui; Craig A Branch; Juri G Gelovani; Steven K Libutti; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

Review 4.  Advanced Pancreatic Neuroendocrine Neoplasms: Which Systemic Treatment Should I Start With?

Authors:  Victor Rodriguez-Freixinos; Alia Thawer; Jaume Capdevila; Diego Ferone; Simron Singh
Journal:  Curr Oncol Rep       Date:  2021-05-03       Impact factor: 5.075

Review 5.  An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs).

Authors:  Teresa Alonso-Gordoa; Juan José Díez; Javier Molina; Pablo Reguera; Olga Martínez-Sáez; Enrique Grande
Journal:  Rare Cancers Ther       Date:  2015-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.